Browsing by Subject "SLC6A2"
Now showing items 1-1 of 1
-
CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders
(Pharmacogenomics and personalized medicine, 2022, vol. 15, p. 951-957, 2022-11)Purpose Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ...